期刊文献+

骨形成蛋白3在肝门部胆管癌组织中的表达及其临床意义 被引量:1

Expression and clinical significance of bone morphogenetic protein 3 in hilar cholangiocarcinoma tissues
下载PDF
导出
摘要 目的:探讨肝门部胆管癌组织中骨形成蛋白3(BMP3)的表达情况及其临床意义。方法:收集30例肝门部胆管癌的临床标本,应用real-time PCR和Western blot检测BMP3 mRNA和蛋白在癌组织和癌旁组织的相对表达情况。收集103例肝门部胆管癌石蜡标本,免疫组织化学法检测肿瘤组织中BMP3蛋白的表达,并分析其与临床病理的关系。结果:全组30例肝门部胆管癌组织中,22例癌组织BMP3蛋白和mRNA的表达水平较癌旁组织明显下降。免疫组织化学方法显示103例肝门部胆管癌组织中,87例阴性,16例弱阳性,BMP3蛋白的表达与肿瘤TNM分期、淋巴结转移、肿瘤的分化程度密切相关(P<0.05)。结论:肝门部胆管癌组织中BMP3基因处于抑制状态,其表达的下调可能与肝门部胆管癌的发生、发展密切相关。 AIM: To investigate the expression and clinical significance of bone morphogenetic protein 3 (BMP3) in hilar cholangiocarcinoma tissues.METHODS: Thirty cases of hilar cholangiocarcinoma specimens were col-lected.The expression of BMP3 at mRNA and protein levels in the tumor tissues and paracancerous tissues was detected by real-time PCR and Western blot.The hilar cholangiocarcinoma paraffin-embedded specimens (n=103) were collected. The protein expression of BMP3 was determined by immunohistochemical method, and the relationship of BMP3 protein ex-pression with clinical pathological characteristics was evaluated.RESULTS:In the 30 patients with hilar cholangiocarcino-ma, the expressions of BMP3 protein and mRNA in 22 cases of tumor tissues were significantly decreased compared with the adjacent normal tissues.The results of immunohistochemistry showed that 87 cases were negative and 16 cases were weakly positive in all 103 cases of hilar cholangiocarcinoma.The expression of BMP3 protein was associated with the tumor TNM staging, lymph node metastasis and tumor differentiation (P〈0.05).CONCLUSION:BMP3 gene might be inhibited in human hilar cholangiocarcinoma.The down-regulation of BMP3 gene might be associated with the carcinogenesis and devel-opment of hilar cholangiocarcinoma.
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2015年第4期615-619,共5页 Chinese Journal of Pathophysiology
基金 广东省科技计划(No.2012B061700105) 广州市科技计划(No.201300000187)
关键词 肝门部胆管癌 骨形成蛋白3 Hilar cholangiocarcinoma Bone morphogenetic protein 3
  • 相关文献

参考文献2

二级参考文献16

  • 1Fukase K, Kato M, Kikuchi S, et al. Effect of eradica- tion of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gas- tric cancer: an open - label, randomised controlled trial [J]. Lancet, 2008, 372(9636):392-397.
  • 2Yaghoobi M, Bijarchi R, Narod SA. Family history and the risk of gastric cancer [J]. Br J Cancer, 2010, 102 (2) :237 -242.
  • 3Piccirillo SG, Reynolds BA, Zanetti N, et al. Bone mor- phogenetic proteins inhibit the tumorigenic potential of human brain tumour - initiating ceils [ J ]. Nature,2006, 444(7120) :761 -765.
  • 4Miyazaki H, Watabe T, Kitamura T, et al. BMP signals inhibit proliferation and in vivo tumor growth of androgen -insensitive prostate carcinoma ceils [ J ]. Oncogene, 2004,23 ( 58 ) :9326 - 9335.
  • 5Hardwick JC, Kodach LL, Offerhaus GJ, et al. Bone morphogenetic protein signalling in colorectal cancer[J]. Nat Rev Cancer,2008,8(10) :806 - 812.
  • 6Kang MH, Oh SC, Lee HJ, et al. Metastatic function of BMP-2 in gastric cancer cells: the role of PI3K/AKT, MAPK, the NF - KB pathway, and MMP -9 expression [J]. Efxp Cell Res, 2011, 317(12):1746-1762.
  • 7Shirai YT, Ehata S, Yashiro M, et al. Bone morphoge- netic protein- 2 and -4 play tumor suppressive roles in human diffuse -type gastric carcinoma[ J ]. Am J Pathol, 2011, 179 (6):2920-2930.
  • 8Wen XZ, Akiyama Y, Baylin SB, et al. Frequent epige- netic silencing of the bone morphogenetic protein 2 gene through methylation in gastric carcinomas[ J ]. Oncogene, 2006, 25 ( 18 ) :2666 - 2673.
  • 9Luo J, Chen J, Deng ZL, et al. Wnt signaling and hu- man diseases: what are the therapeutic implications? [J]. Lab Invest, 2007 ,87(2) :97 - 103.
  • 10Oshima H, Oguma K, Du YC, et al. Prostaglandin E2, Wnt, and BMP in gastric tumor mouse models [ J ]. Cancer Sci, 2009,100(10) : 1779 - 1785.

共引文献4

同被引文献14

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部